Studies of the RB7 Gene and the p53 Gene in Human Osteosarcomas

References

• Friend S H, Bernards R, Rogelj S, Weinberg R A, Rapaport J M, Albert D M, Dryja T P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Lee W H, Bookstein R, Hong F, Yong L J, Shew J Y, Lee E Y-HR. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987; 235: 1394–1399
   PubMed Web of Science ®Google Scholar
• Fung U K, Murphree A L, T'Ang A, Qian J, Hinrichs S H, Benedict W F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236: 1657–1661
   PubMed Web of Science ®Google Scholar
• Dunn J M, Phillips R A, Becker A J, Gallie B L. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988; 241: 1797–1800
   PubMed Web of Science ®Google Scholar
• T'Ang A, Wu K J, Hashimoto T, Liu W Y, Takahashi R, Shi X H, Mihara K, Zhang F H, Chen Y Y, Du C, Qian J, Lin Y G, Murphree A L, Qiu W R, Thompson T, Benedict W F, Fung YK T. Genomic organization of the human retinoblastoma gene. Oncogene. 1989; 4: 401–407
   PubMed Web of Science ®Google Scholar
• McGee T L, Yandell D W, Dryja T P. Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. Gene 1989; 80: 119–128
   PubMed Web of Science ®Google Scholar
• Dunn J M, Phillips R A, Zhu X, Becker A, Gallie B L. Mutations in the RB1 gene and their effects on transcription. Mol Cell Biol. 1989; 9: 4596–4604
   PubMedGoogle Scholar
• Friend S H, Dryja T P, Weinberg R A. Oncogenes and tumor-suppressing genes. N Engl J Med. 1988; 318: 618–622
   PubMed Web of Science ®Google Scholar
• Hansen M F, Koufos A, Gallie B L, Phillips R A, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee W K. Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 1985; 82: 6216–6220
   PubMed Web of Science ®Google Scholar
• Goddard A D, Balakier H, Canton M, Dunn J, Squire J, Reyes E, Becker A, Phillips R A, Gallie B L. Infrequent genomic rearrangement and normal expression of the putative RB1 gene in retinoblastoma tumors. Mol Cell Biol. 1988; 8: 2082–2088
   PubMed Web of Science ®Google Scholar
• Benedict W F, Fung YK T, Murphree A L. The gene responsible for the development of retinoblastoma and osteosarcoma. Cancer 1988; 62: 1691–1694
   PubMed Web of Science ®Google Scholar
• Toguchida J, Ishizaki K, Sasaki M S, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res. 1988; 48: 3939–3943
   PubMed Web of Science ®Google Scholar
• Scholz R B, Kabisch H, Delling G, Winkler K. Homozygous deletion within the retinoblastoma gene in a native osteosarcoma specimen of a patient cured of a retinoblastoma of both eyes. Pediatr Hematol Oncol. 1990; 7: 265–273
   PubMed Web of Science ®Google Scholar
• Wunder J S, Czitrom A A, Kandel R, Andrulis I L. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. JNCI 1991; 83: 194–200
   PubMed Web of Science ®Google Scholar
• Reissmann P T, Simon M A, Lee W H, Salmon D J. Studies of the retinoblastoma gene in human sarcomas. Oncogene 1989; 4: 839–843
   PubMed Web of Science ®Google Scholar
• Stratton M R, Williams S, Fisher C, Ball A, Westbury G, Gusterson B A, Fletcher C DM, Knight J C, Fung Y K, Reeves B R, Cooper C S. Structural alterations of the RB1 gene in human soft tissue tumors. Br J Cancer 1989; 60: 202–205
   PubMed Web of Science ®Google Scholar
• Stratton M R, Moss S, Warren W, Patterson H, Clark J, Fisher C, Fletcher C DM, Ball A, Thomas M, Gusterson B A, Cooper C S. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 1990; 5: 1297–1301
   PubMed Web of Science ®Google Scholar
• Harbour J W, Lai S L, Whang-Peng J, Gazdar A F, Minna J D, Kaye F. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–357
   PubMed Web of Science ®Google Scholar
• Lee EY-HP, To H, Shew J Y, Bookstein R, Scully P, Lee W H. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218–221
   PubMed Web of Science ®Google Scholar
• Bookstein R, Rio P, Madreperla S A, Hong F, Allred C, Grizzle W E, Lee W H. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 1990; 87: 7762–7766
   PubMed Web of Science ®Google Scholar
• Cheng B J, Scully P, Shew J Y, Lee W H, Vila V, Haas M. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood. 1990; 75: 730–735
   PubMed Web of Science ®Google Scholar
• Chen Y C, Chen P J, Yeh S H, Tien H F, Wang C H, Tang J L, Hong R L. Deletion of the human retinoblastoma gene in primary leukemias. Blood. 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Ginsberg A M, Raffeld M, Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood. 1991; 77: 833–840
   PubMed Web of Science ®Google Scholar
• Masuda H, Miller C, Koeffler H P, Battifora H, Cline M J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 1987; 84: 7716–7719
   PubMed Web of Science ®Google Scholar
• Nigro J M, Baker S J, Preisinger A C, Jessup J M, Hostetter R, Cleary K, Bigner S H, Davidson N, Baylin S, Devilee P, Glover T, Collins F S, Weston A, Modali R, Harris C C, Vogelstein B. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342: 705–708
   PubMed Web of Science ®Google Scholar
• Mulligan L M, Madashewski G J, Scrable H J, Cavenee W K. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 1990; 87: 5863–5867
   PubMed Web of Science ®Google Scholar
• Malkin D, Li F P, Strong L C, Fraumeni J F, Nelson C E, Kim D H, Kassel J, Gryka M A, Bischoff F Z, Tainsky M A, Friend S H. Germ line p53 mutations in a familiar syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250: 1233–1238
   PubMed Web of Science ®Google Scholar
• Li F P, Fraumeni JF, Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome. Ann Intern Med. 1969; 71: 747–752
   PubMed Web of Science ®Google Scholar
• Salzer-Kuntschik M, Brand G, Delling G. Bestimmung des morphologischen Regressionsgrades nach Chemotherapie bei malignen Knochentumoren. Pathologie. 1983; 4: 135–141
   PubMed Web of Science ®Google Scholar
• Shew J Y, Ling N, Yang X, Fodstad O, Lee W H. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (ppl 10 RB) in osteosarcomas and synovial sarcomas. Oncogene Res. 1989; 1: 205–214
   Google Scholar
• Harlow E D, Williamson N M, Ralston R, Helfman D M, Adams T E. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol. 1985; 5: 1601–1610
   PubMed Web of Science ®Google Scholar
• Chirgwin J M, Przybyla A E, MacDonald R J, Rutter W J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 1979; 24: 5294–5299
   Google Scholar
• Horsthemke B, Greger V, Barnert H J, Höpping W, Passarge E. Detection of submicroscopic deletions and a DNA polymorphism at the retinoblastoma locus. Hum Genet. 1987; 76: 257–261
   PubMedGoogle Scholar
• Feinberg A P, Vogelstein A. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1984; 137: 266–267
   PubMed Web of Science ®Google Scholar
• Canning S, Dryja T P. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc Natl Acad Sci USA 1989; 86: 5044–5048
   PubMed Web of Science ®Google Scholar
• Friend S H, Horowitz J M, Gerber M R, Wang X F, Bogenmann E, Li F P, Weinberg R A. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 1987; 84: 9059–9063
   PubMed Web of Science ®Google Scholar
• Toguchida J, Ishizaki K, Nakamura Y, Sasaki M S, Ikenaga M, Kato M, Sugimoto M, Kotoura Y, Yamamuro T. Assignment of common allele loss in osteosarcoma to the subregion 17p13. Cancer Res. 1989; 49: 6247–6251
   PubMedGoogle Scholar
• Romano J W, Ehrhart J C, Duthu A, Kim C M, Appella E, May P. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene. 1989; 4: 1483–1488
   PubMed Web of Science ®Google Scholar
• Malkin D, Gattoni-Celli, Byers R, Lee K, Kassel J, Friend S H. Mutant p53 confers tumorigenicity to a cell line lacking p53: evidence for a second p53 function in tumor formation. Blood. 1990; 76: 238a–239a
   Google Scholar